Quality of Artemisinin-based Combination Therapy for malaria found in Ghanaian markets and public health implications of their use

BACKGROUND: Ghana changed their antimalarial drug policy from monotherapies to Artemisinin-based Combination Therapies in 2004 in order to provide more efficacious medicines for treatment of malaria. The policy change can be eroded if poor quality Artemisinin-based Combination Therapies are allowed...

Descripción completa

Detalles Bibliográficos
Autores principales: Tivura, Mathilda, Asante, Isaac, van Wyk, Albert, Gyaase, Stephaney, Malik, Naiela, Mahama, Emmanuel, Hostetler, Dana M., Fernandez, Facundo M., Asante, Kwaku Poku, Kaur, Harparkash, Owusu-Agyei, Seth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5084396/
https://www.ncbi.nlm.nih.gov/pubmed/27788677
http://dx.doi.org/10.1186/s40360-016-0089-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5084396/
https://www.ncbi.nlm.nih.gov/pubmed/27788677
http://dx.doi.org/10.1186/s40360-016-0089-2

Ejemplares similares